Chronic Kidney Disease

✳️ #TenTweetNephJC ✳️ This week CARDINAL - the largest ever RCT in patients with Alport Syndrome 🧵👇 https://t.co/wrAxJoz1GJ

Nephrology Journal Club

@NephJC

Welcome to #TenTweetNephJC ✳️ 10 tweets #NephJC catch-up ✳️ https://t.co/n8dcopDLPT

Nephrology Journal Club

@NephJC

Next up Isuzinaxib, a pan-NOX inhibitor, in type 2 DM and CKD #KidneyWk https://t.co/CSahlLOZGb

Joel M. Topf, MD FACP

@kidney_boy

1) Welcome to this new #accredited #tweetorial on “Strategies to Apply Current Clinical Trial Data for SGLT2i to Reduce the Progression of CKD,” authored by our ⭐️tweetorialist Edg...

@CKD_ce

@ckd_ce

#Quick_Review 💊 — #Dapagliflozin | SGLT-2 inhibitor 🔵 Indications: – Type 2 Diabetes Mellitus – Heart Failure – Chronic Kidney Disease https://t.co/FxxekHOQGz

Ahmed Abdulrahman

@iPhAhmed

💥KDIGO 2020 Clinical Practice Guideline for Diabetes Management in CKD Tweetorial ☄️Comprehensive Care in DM & CKD ☄️Glycemic Monitoring & Targets ☄️Lifestyle Interventions ☄...

Aisha Shaikh @aisha.shaikh.md on Threads

@aishaikh